A diagnosis of superior vena cava obstruction (SVCO) generally is made on clinical grounds and can be confirmed by SVCO-specific diagnostic tests. When the obstruction is long-standing, clinical recognition may be compromised as venous drainage of the head, neck, chest, and upper extremity is diverted via collateral venous channels that bypass the obstructed superior vena cava. In such situations, only the visualization of this collateral flow will suggest the presence of SVCO. We describe a patient in whom the unanticipated diagnosis of SVCO was first suggested when routine mammography revealed grossly dilated superficial veins of both breasts, which were the result of collateral flow.
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Key words: mammogram; radionuclide venography; superior vena cava obstruction Abbreviation: SVCO ϭ superior vena cava obstruction C linical recognition of superior vena cava obstruction (SVCO) rests on the presence of a constellation of symptoms and signs that result from impaired venous drainage of the head, neck, chest, and upper extremities. SVCO-specific diagnostic tests such as radionuclide venography, contrast venography, and contrastenhanced chest CT scan can be performed to confirm the diagnosis of SVCO. Obstruction of the superior vena cava results in collateral circulation diverted via the internal mammary, azygos, hemiazygos, lateral thoracic, thoracoepigastric, and vertebral veins. 1 The improvement of venous drainage by collateral flow that bypasses the obstructed superior vena cava can allow SVCO to remain unrecognized. If these collateral venous channels are not visualized, SVCO is not suspected and SVCO-specific diagnostic tests are not performed.
This was the case in our patient in whom chronic SVCO was not recognized until collateral flow was first visualized, in the form of grossly dilated superficial veins of the breasts, on routine mammography. A radionuclide superior venacavagram confirmed SVCO.
Case Report
An 80-year-old woman was referred for the evaluation of possible SVCO after a routine mammogram revealed grossly dilated superficial veins of the breast (Fig 1) . A radionuclide superior venacavagram (Fig 2) confirmed that the superior vena cava was obstructed. The superior vena cava was not visualized, and the collateral venous pathways were outlined clearly in the form of the internal thoracic vein on the left, the lateral thoracic vein on the right, and intercostal veins bilaterally.
A review of hospital records indicated that 8 years before, central venous catheter-induced superior vena cava thrombosis and obstruction were suspected during a prolonged and complicated postoperative course following resection of a rectal carcinoma. Since that time, the patient had noted facial and upper arm swelling, headaches in the supine position, and exertional dyspnea, all of which had decreased over the years.
An examination of the patient following the mammographic findings of venous dilatation revealed no facial or upper extremity swelling. The jugular veins were not distended and a few dilated veins were present over the upper anterior chest wall. The chest radiograph revealed no lung or mediastinal masses. The patient was thought to have chronic SVCO as a result of the thrombotic occlusion of the superior vena cava that had been induced by central venous catheter placement in the past.
Discussion
Evidence of impaired venous drainage of the head, neck, chest, and upper extremities leads to the recognition of SVCO. Symptoms include dyspnea, headache, visual disturbances, epistaxis, hoarseness, dizziness, syncope, tongue swelling, and hemoptysis. Recumbency or bending over can exacerbate these symptoms. Physical signs include swelling of the face and upper extremities, jugular venous distension, facial plethora, chest or shoulder swelling, distended thoracic veins, proptosis, glossal or laryngeal edema, conjunctival suffusion, mental status change, impaired visual acuity, and Horner syndrome. 2 Bronchogenic carcinoma remains the most common cause of SVCO. Benign causes include superior vena cava thrombosis and fibrosis following the insertion of central venous catheters, mediastinitis and fibrosis secondary to histoplasmosis and tuberculosis, and benign intrathoracic mass lesions. 3 In acute SVCO, the presence of symptoms and signs of impaired venous drainage of the superior vena cava territory makes the diagnosis obvious. In patients with longstanding SVCOs, the development of collateral venous pathways can allow the SVCO to go unrecognized. These collateral pathways provide venous drainage to the head, neck, chest, and upper extremities, and they empty into the azygos vein and inferior vena cava. These pathways include the following: the internal thoracic-superior-inferior epigastric veins on the left; the lateral thoracicsuperficial epigastric veins on the right; the anterior and posterior intercostal veins; the azygos-accessory hemiazygos-hemiazygos veins; the jugular veins; the vertebral plexus; and the small tributaries of the thoracoabdominal wall and the breast. 4, 5 On radionuclide venography, the lateral thoracic veins, the internal thoracic veins, the accessory hemiazygos veins, and the azygos veins can be seen running vertically (with the latter two veins being medially located), while the intercostal veins run horizontally. 4 The superficial collateral flow via the small tributaries of the chest wall can be visualized on chest inspection and by contrast chest CT scan as dilated veins over the anterior chest wall. Dilated superficial veins of the breast that provide collateral flow have been visualized by mammography. 5 In this patient, we have described the presence of dilated superficial veins of the breast, which were first noted on routine mammography, served to alert the physician to a possible SVCO. As a result, a radionuclide superior venacavagram was performed, and the diagnosis of SVCO was established.
In patients with chronic SVCO, the development of collateral venous pathways that bypass the obstructed superior vena cava can make SVCO clinically occult. In such cases, only the visualization of these collateral pathways will suggest the unanticipated diagnosis of SVCO. Our experience is unique in that a routine mammogram served this purpose. 
Pamidronate Results in

Case Report
We report the case of a 27-year-old woman with CF who presented with severe diffuse bone pain and HPOA, which responded to therapy with IV pamidronate. The patient had moderate bronchiectasis (FEV 1 , 65% of predicted), and chronic Pseudomonas aeruginosa infection. The treatment of pulmonary disease included physiotherapy, therapy with aerosolized bronchodilators, therapy with intermittent nebulized aminoglycosides, and two previous hospital admissions for therapy with IV antibiotics. The patient was well-nourished (body mass index, 24.6 kg/m 2 ), but a liver biopsy had confirmed the presence of biliary cirrhosis, which was complicated by portal hypertension (ie, splenomegaly, thrombocytopenia, and esophageal varices, which had been controlled with sclerotherapy).
In June 1999, the patient presented with an 8-week history of severe bilateral ankle and knee pain, and right elbow and right wrist pain. The pain was being poorly controlled with simple analgesia and was impairing the patient's sleep at night. The pain was associated with severe early-morning stiffness and required leave from full-time employment as a clerical officer. A clinical examination revealed bony tenderness proximal to both ankles, which was associated with minimal ankle edema. There was no clinical evidence of synovitis or of an inflammatory arthritis. The findings of chest and abdominal examinations were unchanged from those of earlier examinations, and the results of spirometry testing were consistent with earlier values. Rheumatoid factor was negative, and antinuclear antibody level was weakly positive (nucleolar pattern, titer 160; the normal reference is Ͻ40 titre). How-
